The Complete Guide to Medical Weight Loss: Semaglutide vs. Tirzepatide
Choosing the right weight loss medication is a medical decision, not a marketing one. This guide breaks down the two most effective GLP-1 medications available today—how they work, what they cost, and how Highland Longevity helps patients in Fort Worth and the DFW area achieve lasting results under physician supervision.
At a Glance
Why We Created This Guide
Evidence-based information from a board-certified obesity medicine physician.
If you're researching medical weight loss in Fort Worth or the DFW area, you've likely seen the names semaglutide and tirzepatide everywhere. Online clinics promise easy prescriptions. Telehealth startups ship medications without a physical exam. And social media is flooded with before-and-after photos that tell you nothing about the medical process behind the results.
At Highland Longevity, we take a different approach. Dr. Joshua Lindsley, DO, DABOM—board-certified in both Obesity Medicine and Emergency Medicine—oversees every patient's weight loss program personally. That means lab work, DEXA body composition scans, resting metabolic rate testing, and ongoing nutrition support—not just a prescription.
This guide gives you the same information we share during consultations: which medication may be right for you, what the treatment process looks like, what realistic results look like month by month, and what it actually costs. No hype. Just evidence.
Semaglutide vs. Tirzepatide: Full Comparison
A side-by-side breakdown of the two most effective GLP-1 weight loss medications available in 2026.
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism of Action | GLP-1 receptor agonist | Dual GIP + GLP-1 receptor agonist |
| Approved-Product Trial Evidence | Results depend on the studied product, dose, population, and duration | Head-to-head approved-product evidence does not establish outcomes for compounded formulations |
| FDA Approval of the Molecule (brand-name only) | Brand-name semaglutide approved 2021 (longer track record). Highland prescribes compounded only. | Brand-name tirzepatide approved 2023. Highland prescribes compounded only. |
| Dosing Schedule | Twice-weekly subcutaneous injection | Twice-weekly subcutaneous injection |
| Common Side Effects | GI (nausea, decreased appetite, mild discomfort) | Similar GI profile |
| Best For | Patients seeking a proven track record, longer safety data | Patients comparing mechanisms, evidence, risks, and tradeoffs |
For a deeper clinical comparison, see our full Semaglutide vs. Tirzepatide Comparison Guide.
Which Medication Is Right for You?
Your goals, medical history, and individual response all play a role. Here's a starting framework.
Consider Semaglutide If:
- You want the molecule with a longer, more extensive clinical track record (semaglutide’s brand-name version was used for weight loss in 2021; Highland prescribes compounded semaglutide, not the brand-name product)
- You've responded well to GLP-1 medications in the past
- You prefer more extensive long-term safety data available
- Insurance coverage or cost considerations favor semaglutide
- You want to compare mechanism, evidence, risks, access, and monitoring needs
Consider Tirzepatide If:
- You want to compare medication mechanisms, evidence, risks, access, and tradeoffs
- You've plateaued on semaglutide and need a new approach
- Diabetes status, A1C, contraindications, and medication indications are reviewed individually
- You didn't tolerate semaglutide well and want to try a different mechanism
- You want the dual-mechanism approach targeting both GIP and GLP-1 pathways
Medication selection is individualized to medical history, contraindications, current medications, tolerability, access, risks, and goals. Follow-up is used to reassess benefit, adverse effects, and whether treatment should continue, change, or stop.
— Dr. Josh Lindsley, DO, DABOM
Your Treatment Process at Highland Longevity
A structured, physician-led approach from first visit to long-term success.
What to Expect: Results Timeline
Realistic month-by-month milestones based on clinical data and our patient outcomes.
- Noticeable appetite reduction within the first week
- Fewer food cravings and reduced portion sizes
- Early energy changes as metabolism adjusts
- Dose titration begins (starting low)
- Metabolic improvements visible in lab work
- Clothing size changes becoming apparent
- Blood pressure and blood sugar improvements
- Side effects typically resolved by now
- Significant health marker improvements
- DEXA scans confirm fat loss and muscle preservation
- Cholesterol, triglycerides, and A1c trending down
- Dose optimization at or near target
- Peak weight loss typically achieved
- Maintenance phase discussion begins
- Possible dose reduction for long-term sustainability
- Comprehensive lab review and body composition check
Individual results vary. Figures based on clinical trial data (STEP and SURMOUNT trials) and Highland Longevity patient outcomes. Results are best achieved with lifestyle modifications including diet and exercise. This is not medical advice—consult your physician.
Frequently Asked Questions
Answers to the most common questions about medical weight loss at Highland Longevity.
No. Highland discusses FDA-approved options first and limits compounding to documented patient-specific needs. We do not dispense Wegovy, Ozempic, Rybelsus, Zepbound, or Mounjaro, which are brand-name products manufactured by Novo Nordisk and Eli Lilly. Compounded medications are prepared by a state-licensed compounding pharmacy under physician supervision and are not FDA-approved.
Cost depends on which medication fits you, compounded semaglutide or compounded tirzepatide, along with your dose and protocol, and your provider walks through it with you at your free consultation. Included services vary by program and are reviewed before treatment.
Generally, candidates have a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. Our board-certified obesity medicine physician evaluates each patient individually during the consultation to determine the best approach for your specific situation.
The most common side effects include nausea (which typically improves after 2–4 weeks), decreased appetite, and mild GI discomfort. Slow dose titration—starting at a low dose and gradually increasing—minimizes these effects. Both medications have similar side effect profiles, and Dr. Lindsley monitors your response closely to adjust dosing as needed.
Highland Longevity is led by Dr. Joshua Lindsley, a board-certified obesity medicine physician (DABOM), who provides in-person monitoring, DEXA body composition tracking, comprehensive lab work, resting metabolic rate testing, and ongoing nutrition support. We don't just write prescriptions—we create a complete, data-driven weight loss program tailored to your body.
Compounded medications are generally not covered by health insurance. Insurance coverage typically applies only to brand-name products such as Wegovy, Ozempic, Zepbound, or Mounjaro — which Highland Longevity does not dispense. Highland prescribes compounded semaglutide and compounded tirzepatide directly, with transparent monthly pricing. Our staff can discuss costs and answer questions during your consultation.
Yes. GLP-1 medications are often combined with peptide therapy, hormone optimization, or dietary counseling for a comprehensive approach to weight loss and metabolic health. During your consultation, your provider will evaluate whether combination therapy may benefit you based on your health profile and goals.
Ready to Start Your Weight Loss Journey?
Book a consultation with Dr. Lindsley to discuss which GLP-1 medication is right for you. We'll create a personalized protocol with body composition tracking and ongoing optimization.
Compounded medication disclaimer: Highland discusses FDA-approved options first and limits compounding to documented patient-specific needs. We do not dispense Wegovy®, Ozempic®, Rybelsus®, Zepbound®, Mounjaro®, or any other brand-name GLP-1 product manufactured by Novo Nordisk or Eli Lilly.
Compounded medications are prepared by a state-licensed compounding pharmacy under the supervision of our physician. Compounded medications are not FDA-approved. They are permitted under federal law when an FDA-approved product cannot meet the patient's clinical needs, or when the FDA designates a shortage. Your physician will discuss the implications, risks, and benefits of compounded therapy at your consultation.